Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
1.
J Infect Dis ; 2024 Feb 08.
Artículo en Inglés | MEDLINE | ID: mdl-38330464

RESUMEN

Genetic variation in Cryptosporidium, a common protozoan gut parasite in humans, is often based on marker genes containing trinucleotide repeats, which differentiate subtypes and track outbreaks. However, repeat regions have high replication slippage rates, making it difficult to discern biological diversity from error. Here, we synthesised Cryptosporidium DNA in clonal plasmid vectors, amplified them in different mock community ratios and sequenced them using next generation sequencing to determine the rate of replication slippage with dada2. Our results indicate that slippage rates increase with the length of the repeat region and can contribute to error rates of up to 20%.

2.
Microbiol Resour Announc ; 10(26): e0036321, 2021 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-34197203

RESUMEN

Cryptosporidium hominis is a protozoan parasite that causes gastrointestinal disease in humans worldwide. Here, we report on draft whole-genome sequences of two clinical isolates of C. hominis that were purified from patients with cryptosporidiosis in New Zealand.

3.
Parasitology ; 148(11): 1288-1292, 2021 09.
Artículo en Inglés | MEDLINE | ID: mdl-34120663

RESUMEN

Coronavirus disease-2019 (Covid-19) nonpharmaceutical interventions have proven effective control measures for a range of respiratory illnesses throughout the world. These measures, which include isolation, stringent border controls, physical distancing and improved hygiene also have effects on other human pathogens, including parasitic enteric diseases such as cryptosporidiosis. Cryptosporidium infections in humans are almost entirely caused by two species: C. hominis, which is primarily transmitted from human to human, and Cryptosporidium parvum, which is mainly zoonotic. By monitoring Cryptosporidium species and subtype families in human cases of cryptosporidiosis before and after the introduction of Covid-19 control measures in New Zealand, we found C. hominis was completely absent after the first months of 2020 and has remained so until the beginning of 2021. Nevertheless, C. parvum has followed its typical transmission pattern and continues to be widely reported. We conclude that ~7 weeks of isolation during level 3 and 4 lockdown period interrupted the human to human transmission of C. hominis leaving only the primarily zoonotic transmission pathway used by C. parvum. Secondary anthroponotic transmission of C. parvum remains possible among close contacts of zoonotic cases. Ongoing 14-day quarantine measures for new arrivals to New Zealand have likely suppressed new incursions of C. hominis from overseas. Our findings suggest that C. hominis may be controlled or even eradicated through nonpharmaceutical interventions.


Asunto(s)
COVID-19/prevención & control , Criptosporidiosis/parasitología , Cryptosporidium/clasificación , SARS-CoV-2 , Zoonosis/parasitología , Animales , Criptosporidiosis/epidemiología , Heces/parasitología , Humanos , Nueva Zelanda/epidemiología , Zoonosis/epidemiología
4.
J Appl Microbiol ; 130(1): 302-312, 2021 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-32639595

RESUMEN

AIM: The aim of our study was to assess the presence and risk of waterborne pathogens in the drinking water of outdoor facilities in New Zealand and track potential sources of microbial contamination in water sources. METHODS AND RESULTS: A serial cross-sectional study with a risk-based sample collection strategy was conducted at 15 public campgrounds over two summer seasons (2011-2012 and 2012-2013). Drinking water supplied to these campgrounds was not compliant with national standards, based on Escherichia coli as an indicator organism, in more than half of the sampling occasions. Campylobacter contamination of drinking water at the campgrounds was likely to be of wild bird origin. Faecal samples from rails (pukeko and weka) were 35 times more likely to return a Campylobacter-positive result compared to passerines. Water treatment using ultraviolet (UV) irradiation or a combination of filtration and UV irradiation or chemicals was more likely to result in water that was compliant with the national standards than water from a tap without any treatment. The use of filters alone was not associated with the likelihood of compliance. CONCLUSIONS: Providing microbiologically safe drinking water at outdoor recreational facilities is imperative to avoid gastroenteritis outbreaks. This requires an in-depth understanding of potential sources of contamination in drinking water sources and the installation of adequate water treatment facilities. SIGNIFICANCE AND IMPACT OF THE STUDY: Our study provides evidence that drinking water without treatment or filter-only treatment in public campgrounds is unlikely to comply with national standards for human consumption and extra water treatment measures such as UV irradiation or chemical treatment are needed.


Asunto(s)
Agua Potable/microbiología , Recreación , Abastecimiento de Agua/estadística & datos numéricos , Animales , Aves , Campylobacter/aislamiento & purificación , Estudios Transversales , Agua Potable/normas , Escherichia coli/aislamiento & purificación , Heces/microbiología , Gastroenteritis/epidemiología , Gastroenteritis/microbiología , Gastroenteritis/prevención & control , Humanos , Nueva Zelanda/epidemiología , Estaciones del Año , Purificación del Agua/métodos , Abastecimiento de Agua/normas
5.
Psychoneuroendocrinology ; 113: 104549, 2020 03.
Artículo en Inglés | MEDLINE | ID: mdl-31884322

RESUMEN

Endogenous cannabinoids (endocannabinoids, eCB) are expressed throughout the body and contribute to regulation of the hypothalamo-pituitary-adrenal (HPA) axis and general stress reactivity. This study assessed the contributions of CB1 receptors (CB1R) in the modulation of basal and stress-induced neural and HPA axis activities. Catheterized adult male rats were placed in chambers to acclimate overnight, with their catheters connected and exteriorized from the chambers for relatively stress-free remote injections. The next morning, the CB1R antagonist AM251 (1 or 2 mg/kg) or vehicle was administered, and 30 min later, rats were exposed to loud noise stress (30 min) or no noise (basal condition). Blood, brains, pituitary and adrenal glands were collected immediately after the procedures for analysis of c-fos and CB1R mRNAs, corticosterone (CORT) and adrenocorticotropin hormone (ACTH) plasma levels. Basally, CB1R antagonism induced c-fos mRNA in the basolateral amygdala (BLA) and auditory cortex (AUD) and elevated plasma CORT, indicating disruption of eCB-mediated constitutive inhibition of activity. CB1R blockade also potentiated stress-induced hormone levels and c-fos mRNA in several regions such as the bed nucleus of the stria terminalis (BST), lateral septum (LS), and basolateral amygdala (BLA) and the paraventricular nucleus of the hypothalamus (PVN). CB1R mRNA was detected in all central tissues investigated, and the adrenal cortex, but at very low levels in the anterior pituitary gland. Interestingly, CB1R mRNA was rapidly and bidirectionally regulated in response to stress and/or antagonist treatment in some regions. eCBs therefore modulate the HPA axis by regulating both constitutive and activity-dependent inhibition at multiple levels.


Asunto(s)
Células Neuroendocrinas/fisiología , Receptor Cannabinoide CB1/fisiología , Corteza Suprarrenal/metabolismo , Glándulas Suprarrenales/metabolismo , Hormona Adrenocorticotrópica/sangre , Animales , Corticosterona/sangre , Endocannabinoides/farmacología , Sistema Hipotálamo-Hipofisario/efectos de los fármacos , Sistema Hipotálamo-Hipofisario/metabolismo , Hipotálamo/metabolismo , Masculino , Células Neuroendocrinas/efectos de los fármacos , Células Neuroendocrinas/metabolismo , Sistemas Neurosecretores/metabolismo , Núcleo Hipotalámico Paraventricular/metabolismo , Piperidinas/farmacología , Sistema Hipófiso-Suprarrenal/metabolismo , Proteínas Proto-Oncogénicas c-fos/sangre , Pirazoles/farmacología , Ratas , Ratas Sprague-Dawley , Receptor Cannabinoide CB1/efectos de los fármacos , Receptor Cannabinoide CB1/metabolismo , Restricción Física/psicología , Estrés Fisiológico/fisiología , Estrés Psicológico/fisiopatología
6.
J Ethnopharmacol ; 244: 112123, 2019 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-31356967

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Participatory research can help to broaden the understanding of medical systems and beliefs of traditional communities. An ethnopharmacological survey in collaboration with local people focused on plants used in quilombos located in Southeast Region in Brazil identified cultural factors that influence plant and recipe choice. AIM OF THE STUDY: To investigate the factors related to the therapeutic efficiency of medicinal plants from the perspective of Quilombo da Fazenda residents. MATERIALS AND METHODS: University researchers collaborated with community residents for both aims and methods of the study. The local partners were trained in the gathering of ethnopharmacological data and then selected and interviewed the residents considered experts on the use of medicinal plants. Data on the use of each species were supported by voucher specimens collected by the local partners and university researchers. Participant observations and field diaries by the university researchers supplemented the data. RESULTS: Eight interviewees mentioned 92 medicinal species with 60 therapeutic uses, applied in 208 recipes or remedies. Asteraceae (13 species), Lamiaceae (5) and Urticaceae (5) contributed most medicinal plant species. Of the 12 etic categories of use, the circulatory system category had the highest number of plants mentioned. Decoction was the most commonly used preparation method (66.8%), and most remedies were administered orally (76.4%). Eighty-six recipes included more than one plant species and/or the addition of other components, such as sugar, salt or animal products. Several cultural factors influence medicinal plant use. Popular beliefs on the quality of blood or the humoral properties of plants and illnesses, characteristics of the plants and other factors determine which plant is used and why. CONCLUSIONS: The participatory method identified a large number of factors that influence medicinal plant use: the patient's blood type; the condition of the plant and the disease (hot-cold system); the route of administration and dosage; the preventive uses of the plants; and the influence of other factors, such as the sun, the moon and dew. The participatory approach is useful for gaining insight on the decision processes of medicinal plant use in traditional societies, and also for those communities wanting to document their knowledge with or without the participation of the academy.


Asunto(s)
Medicina Tradicional , Plantas Medicinales , Adulto , Anciano , Anciano de 80 o más Años , Brasil , Etnofarmacología , Femenino , Conocimientos, Actitudes y Práctica en Salud , Humanos , Magnoliopsida , Masculino , Persona de Mediana Edad , Fitoterapia , Encuestas y Cuestionarios
10.
J. clin. oncol ; 24(7): 1161-1168, 2006.
Artículo en Inglés | Coleciona SUS | ID: biblio-945214

RESUMEN

To evaluate the impact of chemotherapy and surgery on the outcome of osteosarcoma (OS) of the extremities and to identify prognostic factors in Brazilian patients. A total of 225 patients with metastatic and nonmetastatic OS of the extremities were enrolled and assessed in two consecutive studies designed and implemented by the Brazilian Osteosarcoma Treatment Group. The 5-year survival and event-free survival rates for the 209 assessable patients were 50.1% and 39%, respectively; for the 178 patients with nonmetastatic disease at diagnosis, the rates were 60.5% and 45.5%, respectively. The multivariate analysis showed that the following variables were associated with a shorter survival: metastases at diagnosis (P < .001), necrosis grades 1 and 2 (P = .046), and tumor size (P = .0071). The overall 5- and 10-year survival rates were lower than the rates reported in North American and European trials. A pattern of advanced disease at diagnosis was often present, with a high proportion of patients having metastases (20.8%) and large tumor size (42.9%). However, these features were not necessarily associated with longer duration of prediagnostic symptoms. These findings were considered in the strategic planning of the current Brazilian cooperative study, with the aim of improving survival and quality of life of a large number of patients with OS.


Asunto(s)
Humanos , Estudios de Casos y Controles , Metástasis de la Neoplasia , Osteosarcoma/diagnóstico , Osteosarcoma/tratamiento farmacológico
11.
Leuk Lymphoma ; 44(10): 1837-9, 2003 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-14692546

RESUMEN

Primary bone lymphoma (PBL) is a rare entity and comprises about 5% of all extranodal non-Hodgkin's lymphomas (NHL) and 7% of all primary bone tumors. To date there is no consensus about the optimal treatment for PBL. We retrospectively reviewed all cases of PBL treated at Hospital São Paulo, Brazil, over a 10-year-period (January 1992-January 2002). Medical records of 7 patients with PBL were reviewed and information on age at diagnosis, sex, NHL clinical staging (CS), treatment and response to treatment were retrieved. Five patients (72%) received combined-modality therapy (CMT) and all of them are in complete remission (CR) with a median follow up of 19 months (ranging from 12 to 144 months). We conclude that PBL is a potentially curable malignancy and treatment should be undertaken in a multiprofessional approach, in order to provide the best support which probably has to include chemotherapy, radiotherapy and, for patients with IPI higher than 2, consolidation with stem-cell transplantation.


Asunto(s)
Neoplasias Óseas/terapia , Linfoma no Hodgkin/terapia , Adulto , Anciano , Neoplasias Óseas/complicaciones , Terapia Combinada , Femenino , Humanos , Linfoma no Hodgkin/complicaciones , Persona de Mediana Edad , Inducción de Remisión , Estudios Retrospectivos
12.
J Eur Acad Dermatol Venereol ; 15(4): 337-9, 2001 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-11730047

RESUMEN

Acne caused by amineptine has always been described with typical characteristic clinical features, and the retentional and cutaneous lesions are dose related. We present a case of acne-like eruption due to amineptine in a woman under treatment for chronic depression.


Asunto(s)
Erupciones Acneiformes/inducido químicamente , Antidepresivos Tricíclicos/efectos adversos , Dibenzocicloheptenos/efectos adversos , Erupciones por Medicamentos/etiología , Erupciones Acneiformes/patología , Trastorno Depresivo/tratamiento farmacológico , Erupciones por Medicamentos/patología , Femenino , Humanos , Persona de Mediana Edad
13.
Clin Infect Dis ; 31(4): 1012-7, 2000 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11049785

RESUMEN

Recurrent Clostridium difficile disease (CDD) is a difficult clinical problem because antibiotic therapy often does not prevent further recurrences. In a previous study, the biotherapeutic agent Saccharomyces boulardii was used in combination with standard antibiotics and was found to be effective in reducing subsequent recurrences of CDD. In an effort to further refine a standard regimen, we tested patients receiving a regimen of a standard antibiotic for 10 days and then added either S. boulardii (1 g/day for 28 days) or placebo. A significant decrease in recurrences was observed only in patients treated with high-dose vancomycin (2 g/day) and S. boulardii (16.7%), compared with those who received high-dose vancomycin and placebo (50%; P=.05). No serious adverse reactions were observed in these patients. Comparison of data from this trial with data from previous studies indicates that recurrent CDD may respond to a short course of high-dose vancomycin or to longer courses of low-dose vancomycin when either is combined with S. boulardii.


Asunto(s)
Antibacterianos/administración & dosificación , Enterocolitis Seudomembranosa/tratamiento farmacológico , Enterocolitis Seudomembranosa/terapia , Probióticos/uso terapéutico , Saccharomyces , Vancomicina/administración & dosificación , Anciano , Clostridioides difficile/efectos de los fármacos , Clostridioides difficile/aislamiento & purificación , Terapia Combinada , Método Doble Ciego , Enterocolitis Seudomembranosa/microbiología , Heces/microbiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Recurrencia
14.
Med Pediatr Oncol ; 33(2): 71-5, 1999 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-10398179

RESUMEN

BACKGROUND: Chemotherapy has dramatically improved the rates of cure and survival of patients with localized and metastatic osteosarcoma. Nonetheless, the number of chemotherapeutic agents active against osteosarcoma is limited to doxorubicin, cisplatin, high-dose methotrexate, and ifosfamide. Carboplatin, a cisplatin analogue, has been tested as a single agent in patients with recurrent osteosarcoma or as part of multiagent chemotherapy in newly diagnosed patients. PROCEDURE: We tested the activity and toxicity of two cycles of intraarterial carboplatin as a "window therapy" (600 mg/m2 per cycle) in 33 consecutive patients with extremity osteosarcoma before the start of multiagent chemotherapy. Response was based on clinical (tumor diameter, local inflammatory signs, and range of motion) and radiological parameters (plain local films and arteriographic studies prior to drug administration). RESULTS: Patients' age ranged between 8 and 18 years (median age 13 years). Primary tumor originated from the femur (15 patients), tibia (10 patients), fibula (4 patients), humerus (3 patients), and calcaneus (1 patient). Only 7 patients (21%) had metastatic disease at diagnosis (5 in the lung and 2 in other bones). A favorable clinical and radiological response was documented in 81% and 73% of the patients, respectively. Clinical and radiological progression occurred in 12% and 9% of the patients, respectively. Seventeen of the patients remain alive and disease-free. Survival and event-free survival at 3 years for nonmetastatic patients are 71% (SE = 9%) and 65% (SE = 9%), respectively; for metastatic patients, the figures are 17% (SE = 15%) and 14% (SE = 13%), respectively. CONCLUSIONS: We conclude that carboplatin is an active agent in the treatment of newly diagnosed extremity osteosarcoma.


Asunto(s)
Antineoplásicos/administración & dosificación , Neoplasias Óseas/tratamiento farmacológico , Carboplatino/administración & dosificación , Osteosarcoma/tratamiento farmacológico , Adolescente , Antineoplásicos/uso terapéutico , Neoplasias Óseas/diagnóstico por imagen , Neoplasias Óseas/patología , Carboplatino/uso terapéutico , Quimioterapia Adyuvante , Niño , Extremidades , Femenino , Humanos , Infusiones Intraarteriales , Masculino , Osteosarcoma/diagnóstico por imagen , Osteosarcoma/secundario , Radiografía , Análisis de Supervivencia
17.
Artículo en Español | PAHO | ID: pah-34668

RESUMEN

Clinical, epidemiological, and laboratory circumstances were the cause of an initially erroneous diagnosis of variola minor in the second half of 1967, when the regional virology laboratory studied an epidemic outbreak of an eruptive disease in a rural community with some industry in which very few smallpox vaccinations had been administered. The disease sharply attacked the adult population and spread to municipalities near the capital of the department of Antioquia, Colombia, which two years earlier, had been protected by a mass vaccination campaign


Recourse to the national reference laboratory and the National Communicable Disease Center of the United States was available in connection with a change in diagnosis, discarding smallpox and adopting chikenpox. This was verified within the framework of the PASB smallpox eradication program, which ensures continous reliability for the diagnosis in the laboratory through dependable tests, and clinically by stressing the different features between smallpox and chickenpox, as shown in photographs used in the continous medical education programs(AU)


Asunto(s)
Viruela/diagnóstico , Varicela/diagnóstico , Técnicas de Laboratorio Clínico , Virus de la Viruela/aislamiento & purificación , Herpesvirus Humano 3/aislamiento & purificación
18.
Artículo | PAHO-IRIS | ID: phr-14484

RESUMEN

Clinical, epidemiological, and laboratory circumstances were the cause of an initially erroneous diagnosis of variola minor in the second half of 1967, when the regional virology laboratory studied an epidemic outbreak of an eruptive disease in a rural community with some industry in which very few smallpox vaccinations had been administered. The disease sharply attacked the adult population and spread to municipalities near the capital of the department of Antioquia, Colombia, which two years earlier, had been protected by a mass vaccination campaign


Recourse to the national reference laboratory and the National Communicable Disease Center of the United States was available in connection with a change in diagnosis, discarding smallpox and adopting chikenpox. This was verified within the framework of the PASB smallpox eradication program, which ensures continous reliability for the diagnosis in the laboratory through dependable tests, and clinically by stressing the different features between smallpox and chickenpox, as shown in photographs used in the continous medical education programs.


Asunto(s)
Viruela , Varicela , Virus de la Viruela , Herpesvirus Humano 3
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...